Detalhe da pesquisa
1.
In vitro activity of CP-99,219, a novel 7-(3-azabicyclo[3.1.0]hexyl) naphthyridone antimicrobial.
Diagn Microbiol Infect Dis
; 19(4): 235-43, 1994 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-7851087
2.
The chemistry and biological profile of trovafloxacin.
J Antimicrob Chemother
; 39 Suppl B: 1-14, 1997 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-9222064
3.
Metabolism and excretion of trovafloxacin, a new quinolone antibiotic, in Sprague-Dawley rats and beagle dogs. Effect of bile duct cannulation on excretion pathways.
Drug Metab Dispos
; 24(11): 1231-40, 1996 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-8937858
4.
Anti-Toxoplasma gondii activities and structure-activity relationships of novel fluoroquinolones related to trovafloxacin.
Antimicrob Agents Chemother
; 43(7): 1783-7, 1999 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-10390245
5.
Fluoroquinolone antibacterials: SAR mechanism of action, resistance, and clinical aspects.
Med Res Rev
; 16(5): 433-86, 1996 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-8865150